Healthy adult female
Conditions
Interventions
Trial1: Comparison of different acupoint locations (5-6 groups) Multiple predefined facial acupoint locations will be targeted, and micron-scale protrusion products (gel patches) will be applied. Dif
Sponsors
Niigata University of Health and Welfare
Hisamitsu Pharmaceutical Co., Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1 Healthy adults aged between 20 and 65 years; 2 Individuals with self-reported facial sagging; 3 Individuals who provide informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1 Individuals with a history of allergic reactions or sensitivity to cosmetics; 2 Individuals who are expected to have allergic reactions to any of the ingredients used.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3D Imaging and Analysis Device (VECTRA Handy H2; manufactured by Canfield Scientific, Inc.) for measuring morphological changes before and after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of heart rate variability over time using the myBeat device (heart rate variability monitor) before and after acupoint stimulation, and assessment of subjective changes before and after the intervention (including changes in specific facial points, questionnaire responses such as name, sex, age, height, weight, date and time, pre- and post-treatment status and progress, the short version of the relaxation rating scale, and confirmation of any adverse events). | — |
Countries
Japan
Contacts
Public ContactMichiyo Takano
Niigata University of Health and Welfare Department of Acupuncture, Moxibustion and Health
Outcome results
None listed